Back
Corporate News
Cohance Lifesciences to review financial results at a board meeting November 6, 2026
26-Oct-2026, 07:17
Cohance Lifesciences Limited, formerly Suven Pharmaceuticals Limited, will hold a board meeting on Friday, November 6, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026, the company informed the Bombay Stock Exchange and National Stock Exchange of India. The trading window for designated persons and their immediate relatives will remain closed until November 9, 2026, following a closure initiated on September 28, 2026.